RELMADA THERAPEUTICS, INC. Accrued Bonuses, Current
RELMADA THERAPEUTICS, INC. (RLMD) had Accrued Bonuses, Current of $1.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Accrued Liabilities, Current › Employee-related Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2026-08-06
- 2026-06-30: Accrued Bonuses, Current $1.00M.
- 2026-03-31: Accrued Bonuses, Current $516.30K.
- 2025-09-30: Accrued Bonuses, Current $1.38M.
- 2025-06-30: Accrued Bonuses, Current $1.04M.
| Period end | Accrued Bonuses, Current |
|---|---|
| 2026-06-30 | $1.00M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $516.30K 10-Q · filed 2026-05-12 |
| 2025-09-30 | $1.38M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.04M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $457.30K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $732.30K 10-K · filed 2026-03-19 |
| 2024-09-30 | $970.50K 10-Q · filed 2024-11-07 |
| 2023-12-31 | $2.63M 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |